4.7 Article Book Chapter

Designer drugs: a medicinal chemistry perspective

Journal

ADDICTION REVIEWS
Volume 1248, Issue -, Pages 18-38

Publisher

BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2011.06199.x

Keywords

controlled substances; designer drugs; medicinal chemistry; opioids; analgesics; amphetamines; cannabinoids; PCP; stimulants; hallucinogens

Ask authors/readers for more resources

There are numerous medicinal chemistry reports in the literature describing the pharmacological properties of thousands of narcotics, stimulants, hallucinogens, sedative-hypnotic drugs, cannabinoids, and other psychoactive substances as well as synthetic methods for their preparations. This information, while essential for the advancement of science, has been used by clandestine chemists to manufacture and market an endless variety of analogs of so-called designer drugs. In this review, we describe how clandestine chemists used the principles of medicinal chemistry to design molecules, referred to as designer drugs, that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3′-(substituted pyridinyl)-deschloroepibatidine analogs

Pauline W. Ondachi, Zhuo Ye, Ana H. Castro, Charles W. Luetje, M. Imad Damaj, S. Wayne Mascarella, Hernan A. Navarro, F. Ivy Carroll

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists

Chad M. Kormos, Pauline W. Ondachi, Scott P. Runyon, James B. Thomas, S. Wayne Mascarella, Ann M. Decker, Hernan A. Navarro, F. Ivy Carroll

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Article Biochemistry & Molecular Biology

Synthesis and Characterization of the Selective, Reversible PKCβ Inhibitor (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexade cine-18,20(19H)-dione, Ruboxistaurin (LY333531)

Anita H. Lewin, Larry Brieaddy, Jeffrey R. Deschamps, Gregory H. Imler, S. Wayne Mascarella, P. Anantha Reddy, F. Ivy Carroll

ACS CHEMICAL NEUROSCIENCE (2019)

Article Chemistry, Medicinal

Synthesis and Nicotinic Acetylcholine Receptor in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-3′-(substituted phenyl)deschloroepibatidine Analogues of 2′-Fluoro-3′-(4-nitrophenyl)deschloroepibatidine

Pauline Ondachi, Ana Castro, Charles W. Luetje, M. Imad Damaj, S. Wayne Mascarella, Hernan A. Navarro, F. Ivy Carroll

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

4β-Methyl-5-(3-hydroxyphenyl)morphan Opioid Agonist and Partial Agonist Derived from a 4β-Methyl-5-(3-hydroxyphenyl)morphan Pure Antagonist

F. Ivy Carroll, Moses G. Gichinga, John D. Williams, Eyal Vardy, Bryan L. Roth, S. Wayne Mascarella, James B. Thomas, Hernan A. Navarro

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Chemistry, Medicinal

Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted pyridinyl)-7-deschloroepibatidine Analogues

Pauline W. Ondachi, Ana H. Castro, Jakub M. Bartkowiak, Charles W. Luetje, M. Imad Damaj, S. Wayne Mascarella, Hernan A. Navarro, F. Ivy Carroll

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-N-[1R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)

Chad M. Kormos, Pauline W. Ondachi, Scott P. Runyon, James B. Thomas, S. Wayne Mascarella, Ann M. Decker, Hernan A. Navarro, Timothy R. Fennell, Rodney W. Snyder, F. Ivy Carroll

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)

Pauline W. Ondachi, Chad M. Kormos, Scott P. Runyon, James B. Thomas, S. Wayne Mascarella, Ann M. Decker, Hernan A. Navarro, Timothy R. Fennell, Rodney W. Snyder, F. Ivy Carroll

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Medicine, Research & Experimental

Emergence and properties of spice and bath salts: A medicinal chemistry perspective

Anita H. Lewin, Herbert H. Seltzman, F. Ivy Carroll, S. Wayne Mascarella, P. Anantha Reddy

LIFE SCIENCES (2014)

Article Chemistry, Organic

Synthesis and physicochemical characterization of (6S)-5-formiminotetrahydrofolate; a reference standard for metabolomics

A. H. Lewin, P. Silinski, D. Zhong, A. Gilbert, S. W. Mascarella, H. H. Seltzman

ORGANIC & BIOMOLECULAR CHEMISTRY (2018)

Article Biochemical Research Methods

Synthesis of [3H] and [14C]genipin

Adele E. Queen, David Hesk, David M. Lindsay, William J. Kerr, Kenneth Rehder, Tim Fennell, Wayne Mascarella, Desong Zhong, Scott Runyon

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2020)

Article Multidisciplinary Sciences

Designer drugs: a medicinal chemistry perspective (II)

F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman, P. Anantha Reddy

Summary: The review discusses the exponential increase in clandestine manufacture of new psychoactive substances designed to circumvent regulations, which has led to a rise in fatalities. It focuses on three compound classes and highlights the medicinal chemistry approaches used by clandestine laboratories to develop new substances, as well as the chemical methods for treating illicit drug abuse.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)

Article Chemistry, Multidisciplinary

Isolation of Hemiketal and Hydroxy Ketone Tautomers of Synthetic Intermediates Each Affording 18-Hydroxycortisol-1,6,7-d ( 3 )

Anita H. H. Lewin, James P. P. Hayes, Desong Zhong, Dehui Zhang, Chad M. M. Kormos, S. Wayne Mascarella, Herbert. H. Seltzman

Summary: During the synthesis of deuterated 18-hydroxycortisol, it was discovered that two of the synthetic intermediates exist in tautomeric forms as acyclic 18-hydroxy 20-ketone and cyclic 18,20-hemiketal, corresponding to the previously identified less polar (L) and more polar (M) forms of C-18 hydroxylated steroids. The issues associated with the existence of 18-hydroxysteroids as hydroxy ketones and hemiketals, both in solution and as isolable solids, are discussed.

ACS OMEGA (2023)

Article Biochemistry & Molecular Biology

Caged Naloxone: Synthesis, Characterization, and Stability of 3-O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)

Anita H. Lewin, Scott E. Fix, Desong Zhong, Louise D. Mayer, Jason P. Burgess, S. Wayne Mascarella, P. Anantha Reddy, Herbert H. Seltzman, F. Ivy Carroll

ACS CHEMICAL NEUROSCIENCE (2018)

Article Pharmacology & Pharmacy

Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor

Steven D. Chang, S. Wayne Mascarella, Skylar M. Spangler, Vsevolod V. Gurevich, Hernan A. Navarro, F. Ivy Carroll, Michael R. Bruchas

MOLECULAR PHARMACOLOGY (2015)

No Data Available